Emmaus Life Sciences CEO Willis C. Lee acquires 290,767 common shares worth $14,186.02
EMMA•CEO reports open-market purchases through Roth IRA
Emmaus Life Sciences CEO Willis C. Lee reported open-market purchases of 460,767 common shares through a Fidelity Roth IRA.
Implied purchase prices ranged from USD 0.01 to USD 0.06 per share.
Roth IRA holdings rose to 690,167 shares; Lee also reported 395,124 shares held directly.
